(Q35826064)

10 August 2017

Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitor (English)

1 reference

10 August 2017

1 reference

1 reference

1 reference

Isabelle Poizot-Martin

2

object named as

Isabelle Poizot-Martin

1 reference

10 August 2017

Caroline Solas

1

1 reference

10 August 2017

Marie-Pierre Drogoul

3

1 reference

10 August 2017

Isabelle Ravaux

4

1 reference

10 August 2017

Catherine Dhiver

5

1 reference

10 August 2017

Alain Lafeuillade

6

1 reference

10 August 2017

Thierry Allegre

7

1 reference

10 August 2017

Malika Mokhtari

8

1 reference

10 August 2017

Jacques Moreau

9

1 reference

10 August 2017

Gérard Lepeu

10

1 reference

10 August 2017

Nathalie Petit

11

1 reference

10 August 2017

Alain Durand

12

1 reference

10 August 2017

Bruno Lacarelle

13

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

57

1 reference

10 August 2017

4

1 reference

10 August 2017

436-440

1 reference

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884480

Pharmacokinetic and pharmacodynamic study of the human immunodeficiency virus protease inhibitor amprenavir after multiple oral dosing

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884480

Indinavir concentrations and antiviral effect

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884480

Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884480

ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884480

Simple high-performance liquid chromatographic determination of the protease inhibitor indinavir in human plasma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884480

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884480

High indinavir Cmin is associated with higher toxicity in patients on indinavir-ritonavir 800/100 mg twice-daily regimen

11 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2003.02020.X

Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrations

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884480

Relationship between efficacy, tolerance, and plasma drug concentration of ritonavir in children with advanced HIV infection.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884480

Relationships between exposure to saquinavir monotherapy and antiviral response in HIV-positive patients.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884480

Ritonavir and saquinavir combination therapy for the treatment of HIV infection

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1884480

The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15025741

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1046/J.1365-2125.2003.02020.X

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

15025741

1 reference